Business
Update on 2019 AGM voting outcome
Update on 2019 AGM voting outcome.
About this update from Mountview Estates P.l.c.
[{"type":"text","content":"\n \nRNS Number : 4851C Mountview Estates PLC 10 February 2020 \n\n10 February 2020\n \nMOUNTVIEW ESTATES P.L.C.\n(\"Mountview\" or \"the Company\")\nUpdate on 2019 AGM voting outcome\n \nIn accordance with Provision 4 of the UK Corporate Governance Code, the Company is providing the following update to the 2019 AGM voting results made on 8 August 2019 regarding the significant vote against a number of resolutions:\nResolution 5: re-election of Mrs M.L. Jarvis as a director of the Company\nResolution 6: re-election of Mr A. W. Powell as a director of the Company\nResolution 8: to approve the Directors' Remuneration Report\nResolution 9: to re-appoint Messrs BSG Valentine as auditors of the Company\nIn addition, Resolutions 11 and 12, to re-elect Mrs M.L Jarvis and Mr A.W. Powell as directors of the Company, were not approved by a majority of the Company's independent shareholders. At a subsequent general meeting held on 19 November 2019, as the Company was entitled to convene in accordance with the FCA's Listing Rules, both Mrs M.L. Jarvis and Mr A.W. Powell were re-elected as directors of the Company.\nFollowing the 2019 AGM in August and prior to the general meeting held on 18 November 2019, the Company identified as far as possible those shareholders who did not support the various resolutions and attempted to engage with them to seek their views. They declined to meet or engage. The Company remains committed to shareholder engagement and we will continue to offer to meet with shareholders to take into account their concerns and considerations in the future.\n \n~ ENDS ~\n \n \n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. END MSCURSRRRNUUAAR\n ","length":2991,"tagName":"div"}]